IFF to Highlight Industry-Leading Product Portfolio, Expertise at CPhI Frankfurt
NEW YORK, Oct. 26, 2022 /PRNewswire/ -- IFF's Pharma Solutions division—backed by 300 years of combined cellulosic excipient experience and housing leading brands like Avicel® and METHOCEL™, plus a robust seaweed-based excipient portfolio —will showcase its deep technical expertise, commitment to customers and investment in its team, technology and manufacturing network at this year's CPhI Frankfurt, held Nov.1-3. Experts will detail how IFF delivers pharmaceutical, dietary supplement and biotechnology solutions through its innovative application support, and robust supply chain.
- "IFF remains focused on addressing customers' formulation and manufacturing challenges with real-time solutions that address their needs," said Angela Strzelecki, president, Pharma Solutions, IFF.
- IFF experts will discuss challenges, brainstorm solutions and provide insights into the company's latest investments, industry-leading products and expertise.
- To learn more about IFF's broad portfolio and proven expertise, stop by the CPhI booth, or visit www.iff.com/portfolio/markets/pharmaceutical .
- IFF, the IFF Logo, and all trademarks and service marks denoted with , SM or are owned by IFF or affiliates of IFF unless otherwise noted.